Jun 24, 2025, 20:58
Saving Lives with Guidelines? ISTH 2025: Prophylactic Anticoagulation Reduces VTE by 60% and Mortality by 56%
Marc Carrier posted on X:
”Implementation matters! A guideline-driven VTE prevention program (Vermont Model) led to ~60% of high-risk cancer patients receiving prophylactic anticoagulation—resulting in a 60% reduction in VTE and 56% reduction in death. ISTH 2025, VTE Prevention”
ISTH 2025 is full of surprises we didn’t know we needed. Turns out, guidelines bring common sense to life—eventually!
Marc Carrier, MD, MSc, FRCPC, urges us to adopt the Vermont Model for prophylactic anticoagulation, in pursuit of grand reductions in VTE and death among high-risk cancer patients.
To stay updated on the world of thrombosis, be sure to subscribe to Hemostasis Today.
-
May 24, 2026, 17:13Mahtab Mashayekhi: The Evolving Role of Red Blood Cell Exchange in the Management of SCD
-
May 24, 2026, 17:12Silvina Graña: Helping Families Better Understand Hemophilia and Daily Life With Bleeding Disorders
-
May 24, 2026, 17:11Miikka Vikkula: Key Insights from the ISSVA 2026 World Congress
-
May 24, 2026, 17:10Mathieu Jackson: Proud to Be Present at This Historic Moment for the Global Bleeding Disorders Community
-
May 24, 2026, 17:09Ramina Fazeli: Highlighting the Emerging Role of Neutrophil Extracellular Traps in Ovarian Cancer
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration
-
May 24, 2026, 15:33Mohammed Zubair: AI-Driven Innovation in Stroke Diagnosis and Medical Imaging